ETFs positioned on Vertex Pharmaceuticals Incorporated

Name YTD change Weight AuM
+13.34%-.--% 44,934 M€
+19.07%-.--% 35,761 M€
+8.27%-.--% 28 M€
+0.95%-.--% 33 M€
+14.82%-.--% 33 M€
+6.30%-.--% 37 M€
+3.89%-.--% 49 M€
+9.01%-.--% 66 M€
+10.79%-.--% 67 M€
+7.22%-.--% 75 M€
+6.54%-.--% 80 M€
+13.76%-.--% 122 M€
+2.42%-.--% 293 M€
+11.71%-.--% 27,154 M€
+17.43%-.--% 750 M€
+9.67%-.--% 507 M€
+4.66%-.--% 165 M€
+19.35%-.--% 148 M€
+28.54%9.51% 15 M€
+23.65%9.43% 429 M€
+17.68%9.05% 78 M€
+17.48%9.05% 1,079 M€
+18.79%8.88% 9,953 M€
+18.41%8.54% 81 M€
+21.08%4.47% 7 M€
+5.97%4.4% 28 M€
+26.02%4.33% 11 M€
+48.56%4.15% 58 M€
+47.06%4.13% 87 M€
Logo Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated specializes in the research, development and marketing of micromolecular drugs primarily for the treatment of cancers, viral, inflammatory and auto-immune diseases. Net sales are distributed geographically as follows: the United States (62.9%), Europe (28.8%) and other (8.3%).
Employees
6,400
  1. Stock Market
  2. Stocks
  3. VRTX Stock
  4. ETFs Vertex Pharmaceuticals Incorporated